A multicenter study from China indicated a significant reduction in CTRP3 levels in Alzheimer’s disease-related cognitive impairment, suggesting that CTRP3 may serve as a potential biological marker for neurodegenerative disorders, possibly related to aging (Huang et al., 2024). This evidence concerns the gene C1QTNF3 and early-onset autosomal dominant Alzheimer disease.